Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2025
A Pioneering Artificial Intelligence Tool To Predict Treatment Outcomes in Ovarian Cancer via Diagnostic Laparoscopy, Xiaotian Ma, Yu-Chun Hsu, Amma Asare, et al.
Overcoming CD226-Related Immune Evasion in Acute Myeloid Leukemia With CD38 CAR-Engineered NK Cells, Luciana Melo Garcia, Achintyan Gangadharan, Pinaki Banerjee, et al.
Histone Methyltransferase ASH1L Primes Metastases and Metabolic Reprogramming of Macrophages in the Bone Niche, Chenling Meng, Kevin Lin, Wei Shi, et al.
POLARIS: Encorafenib Plus Binimetinib for People With BRAF V600-Mutant Melanoma With Brain Metastasis, Alexander M Menzies and Michael A Davies
A Plain Language Summary of POLARIS: A Study To Look at Different Doses of Encorafenib Plus Binimetinib for People With BRAF V600-Mutant Melanoma With Brain Metastasis, Alexander M Menzies, Georgina V Long, Amiee Kohn, et al.
Antitumor Activity and Biomarker Analysis for TROP2 Antibody-Drug Conjugate Datopotamab Deruxtecan in Patient-Derived Breast Cancer Xenograft Models, Funda Meric-Bernstam, Erkan Yuca, Kurt W Evans, et al.
Can the Discovery of High-Impact Diagnostics Be Improved by Matching the Sampling Rate of Clinical Diagnostics to the Frequency Domain of Diagnostic Information?, Steven W Millward, Peng Wei, David Piwnica-Worms, et al.
Can the Discovery of High-Impact Diagnostics Be Improved by Matching the Sampling Rate of Clinical Diagnostics to the Frequency Domain of Diagnostic Information?, Steven W Millward, Peng Wei, David Piwnica-Worms, et al.
Advancing Drug Development in Myelodysplastic Syndromes, Alain Mina, Kathy L McGraw, Lea Cunningham, et al.
Bronchoalveolar Lavage Cell Percentages As Diagnostic Markers of Immune Checkpoint Inhibitor Pneumonitis, Mahnoor Mir, Felipe Soto, Pedro Antonio Amezcua Gomez, et al.
Intratumoral Neutrophil-to-Lymphocyte Ratio Is Mirrored by Circulating Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer, Kyle G Mitchell, Younghee Lee, Nathaniel Deboever, et al.
New Onset Diabetes Predicts Clinical Outcomes in Patients With Pancreatic Adenocarcinoma, Chirayu Mohindroo, Paul S Dy, Suraj P Hande, et al.
Molecular Profiling of Bladder Cancer Xenografts Defines Relevant Molecular Subtypes and Provides a Resource for Biomarker Discovery, Sharada Mokkapati, Ganiraju Manyam, Alexis R Steinmetz, et al.
Anti-CTLA-4 Generates Greater Memory Response Than Anti-PD-1 via TCF-1, Stephen Mok, Huey Liu, Didem Ağaç Çobanoğlu, et al.
SSTR2-Targeted Theranostics in Hepatocellular Carcinoma, Majid Momeny, Solmaz AghaAmiri, Servando Hernandez Vargas, et al.
Neurotransmitter Power Plays: The Synaptic Communication Nexus Shaping Brain Cancer, Jayanta Mondal and Jason T Huse
Brd7 Loss Reawakens Dormant Metastasis Initiating Cells in Lung by Forging an Immunosuppressive Niche, Jayanta Mondal, Junfeng Zhang, Feng Qing, et al.
Single-Cell Analysis of Neoplastic Plasma Cells Identifies Myeloma Pathobiology Mediators and Potential Targets, Luz Yurany Moreno Rueda, Hua Wang, Keiko Akagi, et al.
DNA Damage Response Signatures Are Associated With Frontline Chemotherapy Response and Routes of Tumor Evolution in Extensive Stage Small Cell Lung Cancer, Benjamin B Morris, Simon Heeke, Yuanxin Xi, et al.
Phase II Trial of Atezolizumab and Bevacizumab for Treatment of HPV-Positive Unresectable or Metastatic Squamous Cell Carcinoma of the Anal Canal, Van K Morris, Suyu Liu, Kangyu Lin, et al.
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Metastatic Variant Histology (Non-Clear Cell) Renal Cell Carcinoma, Mohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, et al.
Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary Tract, Mohammad Jad Moussa, Georges C Tabet, Arlene O Siefker-Radtke, et al.
Sitravatinib in Combination With Nivolumab Plus Ipilimumab in Patients With Advanced Clear Cell Renal Cell Carcinoma: A Phase 1 Trial, Pavlos Msaouel, Kai Yu, Ying Yuan, et al.
SARS-CoV-2 RNA-Binding Protein Suppresses Extracellular miRNA Release, Hyejin Mun, Chang Hoon Shin, Qingxuan Fei, et al.
Diet and Survival After a Diagnosis of Ovarian Cancer: A Pooled Analysis From the Ovarian Cancer Association Consortium, Christina M Nagle, Torukiri I Ibiebele, Renhua Na, et al.